Satellos Bioscience Inc (MSLE) Hedge Fund Ownership (Q2 2026)

Satellos Bioscience Inc (MSLE)

26 + Investors. Track Smart Money conviction in MSLE. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — MSLE

Based on 26 hedge funds · latest filing: 2026 Q2 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 1Q

For 1 consecutive quarter, more hedge funds reduced or closed their MSLE positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

📊

High ownership — 87% of 0.5Y peak

87% of all-time peak

26 funds currently hold this stock — 87% of the 0.5-year high of 30 funds (reached 2026 Q1). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.

🟠

More sellers than buyers — 41% buying

9 buying13 selling

Last quarter: 13 funds reduced or exited vs 9 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

🔄

Mostly new holders — 100% entered in last year

■ 0% conviction (2yr+) ■ 0% medium ■ 100% new

Only 0 funds (0%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

💰

Value +52% but shares only +13% — price-driven

Value

+52%

+13%

Last quarter: the total dollar value of institutional holdings rose +52%, but actual share count only changed +13%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.

🌱

Early stage — 100% of holders entered in last year

■ 0% veterans ■ 0% 1-2yr ■ 100% new

Of 26 current holders: 26 (100%) entered in the past year, only 0 (0%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.

📋

Smaller funds dominant — 16% AUM from top-100

16% from top-100 AUM funds

8 of 26 holders rank in the top 100 by AUM, but together hold only 16% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

5.3

out of 10

Moderate Exit Risk

Exit risk score 5.3/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q2)	Prior (2026 Q1)	Change
Funds Holding	26	30	-13.33%
13F Shares	8M	7M	13.28%
Total Value	$60M	$39M	52.34%
New Positions	3	30	-27
Increased Positions	6	0	+6
Closed Positions	7	0	+7
Reduced Positions	6	0	+6
Total Calls	0	0	-
Total Puts	0	0	-
PUT/CALL Ratio	0.0	0.0	Bullish

Metric

All 13F Filers (2026 Q2)

Prior (2026 Q1)

Change

Funds Holding

-13.33%

13F Shares

13.28%

Total Value

$60M

$39M

52.34%

New Positions

-27

Increased Positions

Closed Positions

Reduced Positions

Total Calls

Total Puts

PUT/CALL Ratio

0.0

Bullish

Institutional Holders (2026 Q2)

26 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in MSLE. Verified SEC 13F-HR filings.

QUARTER:

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 MSLE holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Stonepine Capital Management, LLC	1.74%	491,624	$3.7M
2	Empery Asset Management, LP	0.96%	107,100	$833K
3	Sphera Funds Management LTD.	0.66%	652,590	$5.1M
4	Vivo Capital, LLC	0.58%	813,666	$6.3M
5	Avidity Partners Management LP	0.48%	387,769	$3.0M
6	Saturn V Capital Management LP	0.39%	350,000	$2.7M
7	Siren, L.L.C.	0.14%	892,074	$6.9M
8	AWM Investment Company, Inc.	0.12%	180,000	$1.4M
9	683 Capital Management, LLC	0.09%	230,833	$1.8M
10	Soleus Capital Management, L.P.	0.08%	314,359	$2.4M
11	ADAR1 Capital Management, LLC	0.08%	222,555	$1.7M
12	Montanova Capital, LLC	0.07%	475,000	$3.7M
13	Woodline Partners LP	0.01%	500,432	$3.9M
14	China Universal Asset Management Co., Ltd.	0.01%	20,000	$156K
15	Point72 Asset Management, L.P.	0.01%	682,700	$5.3M
16	Adage Capital Partners GP, L.L.C.	0.00%	150,000	$1.2M
17	Franklin Resources Inc	0.00%	938,666	$7.2M
18	Millennium Management LLC	0.00%	152,768	$1.2M
19	Citadel Advisors LLC	0.00%	67,738	$527K
20	Royal Bank of Canada	0.00%	15,863	$124K
21	Morgan Stanley	0.00%	25,732	$200K
22	Caitong International Asset Management Co., Ltd	0.00%	1	—
23	UBS Group AG	0.00%	781	$6K
24	Federation des caisses Desjardins du Quebec	0.00%	19	—
25	Jpmorgan Chase & Co	0.00%	315	$2K

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Satellos Bioscience Inc (MSLE)

What does the Smart Money Trend signal show for MSLE?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their MSLE positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for MSLE?

More sellers than buyers — 41% buying: Last quarter: 13 funds reduced or exited vs 9 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for MSLE holders?

Smaller funds dominant — 16% AUM from top-100: 8 of 26 holders rank in the top 100 by AUM, but together hold only 16% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held MSLE?

Mostly new holders — 100% entered in last year: Only 0 funds (0%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Satellos Bioscience Inc (MSLE)

Smart Money Signals — MSLE

Selling streak — 1 quarter in a row

High ownership — 87% of 0.5Y peak

More sellers than buyers — 41% buying

Mostly new holders — 100% entered in last year

Value +52% but shares only +13% — price-driven

Early stage — 100% of holders entered in last year

Smaller funds dominant — 16% AUM from top-100

Institutional Sentiment Summary — MSLE

Hedge Fund Ownership: MSLE

Market Analysis: MSLE

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: MSLE

Hedge Fund Positioning: MSLE

Statistics: MSLE

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Satellos Bioscience Inc (MSLE)

Welcome to 13Foresight!